Middle East & Africa IVD Devices Contract Manufacturing Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The Middle East and Africa IVD Devices Contract Manufacturing Market size is expected to reach US$ 1,938.0 Million by 2034 from US$ 805.7 Million in 2025. The market is estimated to record a CAGR of 10.2% from 2026 to 2034.

Executive Summary and Middle East and Africa IVD Devices Contract Manufacturing Market Analysis:

The Middle East & Africa IVD devices contract manufacturing market is segmented into Saudi Arabia, South Africa, UAE, Rest of Middle East & Africa. The market landscape is expanding, driven by healthcare infrastructure development and local production incentives. In the UAE and Saudi Arabia, government MoUs worth millions promote domestic manufacturing, with companies such as PureHealth and Julphar boosting exports. Trends emphasize partnerships, such as Gabri Labs' facility in Dubai for cutting-edge devices. Statistics indicate steady growth, with South Africa, UAE, and Kuwait adopting high-tech IVD, where contract manufacturers expand via joint ventures. For example, Codix Pharma's IVD plant in Nigeria enhances local capacity for tests such as PCR and immunoassays. The region sees rising outsourcing, with CMOs providing device development and assembly to meet chronic disease demands. ~60% of diagnostic firms outsource to cut costs by 25%, post-COVID. In South Africa, regulatory expansions support IVD production for hospitals. Government support scales kits for infectious diseases, with MEA holding potential for high-growth areas such as molecular diagnostics. Partnerships with players such as Roche and Siemens strengthen the ecosystem. This fosters innovation in point-of-care testing, addressing accessibility in remote areas and improving patient outcomes through reliable, localized manufacturing.

Middle East & Africa IVD Devices Contract Manufacturing Market: Strategic Insights

Middle East and Africa IVD Devices Contract Manufacturing Market Segmentation Analysis:

• By Service Type, the Middle East and Africa IVD Devices Contract Manufacturing Market is segmented into Full-device Manufacturing, Sub-assembly and Components, and Materials-specific Services. The Full-device Manufacturing segment dominated the market in 2025.
• By Device Type, the Middle East and Africa IVD Devices Contract Manufacturing Market is segmented into IVD Consumables and IVD Equipment. The IVD Consumables segment dominated the market in 2025.

Middle East & Africa IVD Devices Contract Manufacturing Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa IVD Devices Contract Manufacturing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Middle East and Africa IVD Devices Contract Manufacturing Market Outlook

The integration of artificial intelligence (AI) and automation aims to enhance production efficiency and quality control. As contract manufacturers adopt AI-driven systems, they can achieve real-time monitoring of assembly lines, predictive maintenance, and automated defect detection, reducing human error and ensuring compliance with stringent regulatory standards. For instance, AI-powered quality control is being used to inspect high-precision components in diagnostic devices such as blood glucose monitors, where machine learning algorithms analyze imaging data to identify inconsistencies that might otherwise go unnoticed. This trend is driven by the need for scalable, flexible manufacturing that can handle complex IVD products such as immunoassays and molecular assays. Statistics indicate that automation is transforming the sector, with robotics enabling smart manufacturing processes that provide transparency and traceability throughout production. In developing economies, suppliers are upgrading their capabilities to incorporate these technologies, shifting away from traditional methods to protect intellectual property and meet global demands. According to industry insights, over 500 competitors worldwide are actively integrating automation to support higher value-added applications such as point-of-care immunoassays. Furthermore, the adoption of Industry 4.0 concepts, including AI and machine learning for quality assurance, is poised to reshape manufacturing landscapes by streamlining workflows and boosting product reliability. This allows contract manufacturers to offer customized solutions, from reagent production to instrument assembly, helping IVD companies accelerate commercialization without in-house investments. As a result, partnerships between original equipment manufacturers (OEMs) and contract development and manufacturing organizations (CDMOs) are increasing, with examples such as major producers, such as Abbott Diagnostics and Roche Diagnostics, outsourcing to specialized firms for consistent quality and innovation. Overall, this trend promises to make IVD manufacturing more agile and cost-effective, addressing the growing complexity of diagnostic tools in healthcare.

Middle East and Africa IVD Devices Contract Manufacturing Market Country Insights

By country, the Middle East and Africa IVD Devices Contract Manufacturing Market is segmented into Saudi Arabia, South Africa, the United Arab Emirates, and the Rest of Middle East and Africa. South Africa held the largest share in 2025.

South Africa's IVD devices contract manufacturing operates under the South African Health Products Regulatory Authority (SAHPRA), featuring a risk-based framework aligned with IMDRF, WHO, FDA, and EU MDR guidelines. This includes pre-market authorization, licensing, and post-market surveillance, requiring ISO 13485 compliance for quality management. The system classifies devices by risk, with higher classes undergoing rigorous evaluations to ensure safety and efficacy.

Prominent examples encompass Flex, Ltd., providing end-to-end CDMO services for IVD devices, including assembly and quality assurance. Integer Holdings Corporation offers specialized manufacturing for diagnostic imaging components. Gerresheimer AG focuses on packaging and reagent fill-finish for immunoassays. Sanmina Corporation provides electronics integration for POC analyzers. Local players such as Nipro extend contract services for clinical chemistry kits.

Chronic diseases affect 25-30% of the population, with annual IVD test growth due to infectious and NCD burdens. Over 200 medical device manufacturers contribute, with 15% focusing on IVDs. Trends include increasing localization to cut costs, with a 10% rise in outsourcing for compliance amid regulatory updates. Focus on AI and multiplex testing grows, driven by healthcare infrastructure improvements and partnerships with global OEMs.

Middle East and Africa IVD Devices Contract Manufacturing Market Company Profiles

Some of the key players operating in the market include TE Connectivity Ltd, Jabil Inc, Nova Biomedical Corporation, Flex Ltd, Celestica Inc, Fujirebio Europe NV, Thermo Fisher Scientific Inc., Nemera, SMC Ltd, and HiArc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East and Africa IVD Devices Contract Manufacturing Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise